Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1
Treatment of primary colorectal cancer xenografts with the small-molecule BMI-1 inhibitor PTC-209 resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth
Na/c25-15(7-4-3-6-13-18-12(11-34-13)22-20(29)23-18)21-9-5-1-2-8-17(27)33-24-16(26)10-14(19(24)28)35(30
InChi: InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8
Epub 2019 Mar 31
PR-39 - CAS# 139637-11-9 Catalog No.:M13042-10 Activation of the Cdc42-associated tyrosinePR 39, a natural proline and arginine rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. PR 39 reversibly binds to the 7 subunit of the proteasome and blocks degradation of NF B inhibitor IB by the ubiquitin proteasome pathway. PR 39 stimulates angiogenesis, inhibits inflammatory responses and significant reduces myocardial infarct size in mice. Product information CAS Number: 139637 11 9 Molecular Weight:
US$ 298.50
US$ 106.99
US$ 225.00
US$ 45.00
US$ 125.50
US$ 10.00
US$ 32.00
US$ 110.50
US$ 143.00
US$ 810.00
US$ 15.00
US$ 75.00
US$ 12.00
US$ 10.00